Hybrid vs sequential therapy for eradication of Helicobacter pylori in Taiwan: A prospective randomized trial

Table 1 Demographic distribution of the subjects receiving different eradication regimens

Characteristic	Hybrid therapy (n = 88)	Sequential therapy (n = 87)	P value
Age (mean ± SD), yr	52.1 ± 13.0	54.6 ± 13.2	0.26
Gender (male/female)	39/49	25/62	0.04
Smoking	14	6	0.10
Alcohol consumption	20	18	0.74
Ingestion of coffee	61	57	0.59
NSAID user	8	8	0.96
Underlying diseases	26	23	0.77
Endoscopic finding (Peptic ulcer/non-ulcer dyspepsia)	46/42	32/55	0.06
Helicobacter pylori density (mild/moderate/marked)	8/42/38	4/57/26	0.26